The FM/a test is still new and subject to research. Many doctors don’t use it yet, and insurers may not cover the cost. Doctors may still use current diagnostic criteria as confirmation. Fibromyalgia ...

Please provide your email address to receive an email when new articles are posted on . Aromatic amino acids and peptide backbones “most effectively discriminated” fibromyalgia from other rheumatic ...

COLUMBUS, Ohio (WPVI) -- Ohio State University Wexner Medical Center has developed the first blood test for fibromyalgia, a condition at least 4 million people - mostly women, experience. Fibromyalgia ...

Anyone who has experienced severe, chronic pain knows the long process it takes to get a correct diagnosis. Many people see an average of 5-6 specialists before getting a definitive diagnosis.

Currently, a fibromyalgia diagnosis is a "diagnosis of elimination" based on self-reported symptoms. And research suggests that, because of this fibromyalgia is often misdiagnosed and under diagnosed.

The consumer watchdog group the Center for Science in the Public Interest filed a lawsuit against a diagnostics company called EpicGenetics on Wednesday, alleging that the company is making false and ...

New research finds an accurate way of diagnosing fibromyalgia and differentiating it from other related conditions. Using blood samples and innovative techniques, scientists have detected a “molecular ...

Nashville-based data science company IQuity has announced the release of IsolateFibromyalgia ™, a pioneering blood test that uses RNA analysis to help health care providers accurately and quickly ...

PITTSBURGH (KDKA) -- Barbara Hartong's problems began after a fall. "I missed three stairs here in my home," she said. Afterwards, she had puzzling symptoms. "The pain was excruciating in my muscles.

LOS ANGELES--(BUSINESS WIRE)--EpicGenetics, the biomedical company that developed and offers the FM/a Test, the FDA-compliant diagnostic blood test that identifies the immune system biomarkers of ...

LOS ANGELES--(BUSINESS WIRE)--After analyzing thousands of patients, EpicGenetics today announced that its data shows that 80 percent of young people (under 19 years of age) who were tested for ...